Riskpilot← Back to searchSign inGet full accessKomplementarselskabet Danish Pig Genetics ApS
APSActiveCVR 39785765Nordager 2Activities of holding companies · NACE 6421Est. 2018— employees
Revenue 2024
DKK 82K
+2% vs 2023
EBITDA margin
100.0%
+2% vs 2023
Equity ratio
98.1%
Financial strength
Net profit 2024
DKK 41K
+3% vs 2023
| Revenue | DKK 82K | +2% |
| EBITDA | DKK 82K | +2% |
| Net profit | DKK 41K | +3% |
| Total assets | DKK 1,1M | -3% |
| Equity | DKK 1,1M | +4% |
| Employees | — | — |
Legal name
Komplementarselskabet Danish Pig Genetics ApS
CVR number
39785765
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
15. august 2018
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene.
Company purpose
Selskabets formål er at være komplementar i Danish Pig Genetics P/S, CVR-nr. 39 78 59 19, og hermed beslægtet virksomhed.
Address
Nordager 2
Phone
+4581402610
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -10 | -9 | 74 | 81 | 82 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -10 | -9 | 74 | 81 | 82 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -10 | -9 | 74 | 81 | 82 |
| Net financials | 268 | 210 | 1.144 | 66 | 106 |
| Profit before tax | 258 | 202 | 1.218 | 147 | 188 |
| Tax | 226 | 149 | 60 | 106 | 147 |
| Net profit | 32 | 52 | 1.159 | 40 | 41 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 387 | 442 | 1.014 | 1.132 | 1.101 |
| Equity | -212 | -160 | 999 | 1.039 | 1.080 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 599 | 602 | 15 | 93 | 21 |
| Total debt | 599 | 602 | 15 | 93 | 21 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20202024
Equity ratio
98.1%
This company
38.2%
Market median
+157% vs market
20202024
Return on equity
3.8%
This company
18.4%
Market median
-79% vs market
20202024
Net profit margin
50.5%
This company
8.1%
Market median
+523% vs market
20202024
Asset turnover
0.07×
This company
1.12×
Market median
-94% vs market
20202024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (15) | ||
NC Founder | Founder | 2018 |
PR Founder | Founder | 2018 |
KK | Founder | 2018 |
UR Founder | Founder | 2018 |
Rv Management | Management | 2026 |
SD Founder | Founder | 2018 |
FB Founder | Founder | 2018 |
MK Founder | Founder | 2018 |
PM Founder | Founder | 2018 |
MW Chief Executive Officer | Chief Executive Officer | 2026 |
MH Management | Management | 2026 |
JS Founder | Founder | 2018 |
JH Founder | Founder | 2018 |
SS Founder | Founder | 2018 |
PQ Founder | Founder | 2018 |
| Former (5) | ||
HF Chief Executive Officer | Chief Executive Officer | 2022 – 2022 |
JG Chief Executive Officer | Chief Executive Officer | 2022 – 2025 |
NH Management | Management | 2025 – 2025 |
KB Chief Executive Officer | Chief Executive Officer | 2021 – 2021 |
RJ Chief Executive Officer | Chief Executive Officer | 2025 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
| Board of Directors | 2021 – 2025 | |
| Board of Directors | 2021 – 2025 | |
| Chairman | 2021 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 25–33.32% | 25–33.32% | 2025 | |
| Company | 10–14.99% | 10–14.99% | 2018 | |
| Company | 10–14.99% | 10–14.99% | 2018 | |
| Company | 5–9.99% | 5–9.99% | 2022 | |
| Company | 5–9.99% | 5–9.99% | 2018 | |
| Company | 5–9.99% | 5–9.99% | 2022 | |
| Company | 5–9.99% | 5–9.99% | 2018 | |
| Company | 5–9.99% | 5–9.99% | 2020 | |
| Company | 5–9.99% | 5–9.99% | 2022 | |
| Individual | 5–9.99% | 5–9.99% | 2019 | |
| Company | 5–9.99% | 5–9.99% | 2019 | |
| Company | 5–9.99% | 5% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Danish Genetics Holding ApSHendrix Genetics Swine Denmark A/S
Komplementarselskabet Danish Pig Genetics ApS (this company)Board members of Komplementarselskabet Danish Pig Genetics ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Niels Christian Haugaard | Founder | 0 companies |
| Poul Rolighed Nørgaard | Founder | 0 companies |
| Henrik Find Bang Biilmann | Chief Executive Officer | 0 companies |
| Karen Kathrine Damgaard Østergaard | Founder | 0 companies |
| Jan Gerber | Chief Executive Officer | 0 companies |
| Ulrik Rønnenkamp Lundgaard | Founder | 0 companies |
| Roger van Biljouw | Management | 0 companies |
| Niels Henrik Reventlow | Management | 0 companies |
| Svend Demant Møller | Founder | 0 companies |
| Karsten Bo Due | Chief Executive Officer | 0 companies |
| Flemming Bang | Founder | 0 companies |
| Martin Kjær Axel | Founder | 0 companies |
| Poul Martin Egdal | Founder | 0 companies |
| Mikael Wædeled Sigvardsen | Chief Executive Officer | 0 companies |
| Mads Hans Kring | Management | 0 companies |
| Jørgen Salhøj Rask | Founder | 0 companies |
| Rafael Jacobus Henri Gerard Beeren | Chief Executive Officer | 0 companies |
| Jens Himmelstrup | Founder | 0 companies |
| Søren Smedegaard | Founder | 0 companies |
| Poul Quist Iversen | Founder | 0 companies |
| Peter Kejser | Board of Directors | 0 companies |
| Jytte Rosenmaj | Board of Directors | 0 companies |
| Steen Agerbo Bødtker | Chairman | 0 companies |